Neomorph
Biotech · Private
Molecular glue degrader therapeutic targeting undruggable cancer proteins
neomorph.com →- Grants
- —
- No SBIR or STTR on record
- Sector median: 1
- Raised
- —
- No Form D on record
- Contracts
- —
- No federal contracts on record
- Patents
- 13
- 0 granted · 13 pending
- Sector median: 2
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 3356 | Med Aditus Pharmaceuticals, Inc. | — | $5.0M |
| 3357 | CHRONUS PHARMACEUTICALS, INC. | — | — |
| 3358 | True North Therapeutics | — | — |
| 3359 | Neomorph | — | — |
| 3360 | ALPHAMEMORY, LLC | — | — |
| 3361 | CORMEDIX, INC. | — | $3.5M |
| 3362 | ACTINOBAC BIOMED, INC. | — | $3.4M |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Patents
- Piperidinyl Small Molecule Degraders Of Helios And Methods Of Useapplication
- Substituted 3-(5-(4-HYDROXYPIPERIDIN-4-YL)-1-OXOISOINDOLIN-2-YL)PIPERIDINE-2,6-DIONE Derivatives And 3-(2-(4-HYDROXYPIPERIDIN-4-YL)-5-OXO-5,7-DIHYDRO-6H-PYRROLO[3,4-B]PYRIDIN-6-YL)PIPERIDINE-2,6-DIONE Derivatives And Uses Thereofapplication
- Substituted (PIPERIDIN-4-YL)-1,5-NAPHTHYRIDINE And (PIPERIDIN-4-YL)QUINOLINE Derivatives And Uses Thereofapplication
- Subtituted Imidazolyl DIHYDROPYRIMIDINE-2,4-DIONE And Substituted Imidazolyl PIPERIDINE-2,6-DIONE Derivatives And Uses Thereofapplication
- Substituted 3-(5-(4-HYDROXYPIPERIDIN-4-YL)-1-OXOISOINDOLIN-2-YL)PIPERIDINE-2,6-DIONE Derivatives And Uses Thereofapplication
- Substituted (PIPERIDIN-4-YL)-1,5-NAPHTHYRIDINE And (PIPERIDIN-4-YL)QUINOLINE Derivatives And Uses Thereofapplication
- Substituted (PIPERIDIN-4-YL)-1,5-NAPHTHYRIDINE And (PIPERIDIN-4-YL)QUINOLINE Derivatives And Uses Thereofapplication
- Substituted 3-(2-(4-HYDROXYPIPERIDIN-4-YL)-5-OXO-5,7-DIHYDRO-6H-PYRROLO[3,4-B]PYRIDIN-6-YL)PIPERIDINE-2,6-DIONE Derivatives And Uses Thereofapplication
- Piperidinyl Small Molecule Degraders Of Helios And Methods Of Useapplication
- Substituted 3-(2,6-Dioxopiperidin-3-yl)piperidine-2,6-dione Derivatives and Uses Thereofapplication
- Substituted 3-(5-(4-HYDROXYPIPERIDIN-4-YL)-1-OXOISOINDOLIN-2-YL)PIPERIDINE-2,6-DIONE Derivatives And 3-(2-(4-HYDROXYPIPERIDIN-4-YL)-5-OXO-5,7-DIHYDRO-6H-PYRROLO[3,4-B]PYRIDIN-6-YL)PIPERIDINE-2,6-DIONE Derivatives And Uses Thereofapplication
- Subtituted Imidazolyl DIHYDROPYRIMIDINE-2,4-DIONE And Substituted Imidazolyl PIPERIDINE-2,6-DIONE Derivatives And Uses Thereofapplication
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.